Nephros To Present at the Spring Investor Summit on April 1st in New York City

SOUTH ORANGE, NJ, March 29, 2019 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets, today announced that Andy Astor, CFO will be presenting at this year’s Spring Investor Summit on April 1st at 11:30 AM ET in New York City.

The Spring Investor Summit (formerly The MicroCap Conference) is dedicated to connecting small and microcap companies with high-level, institutional and retail investors. It will take place in New York City at the Essex House on April 1st and 2nd. The conference will feature 200 presenting companies. For a list, please go to the conference website (

About Nephros

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters, known as ultrafilters. Nephros ultrafilters are primarily used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas), viruses, and endotoxins from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and the patients.

For more information about Nephros, please visit its website at

Investor Relations Contact:

Andy Astor, COO & CFO
Nephros, Inc.
[email protected]